No silly question when it comes to biotech.
To answer your question the Phase I trial will be an "all comers” trial where patients with any cancer type can be included. This should make the trial recruit relatively fast (you are not looking for a specific cancer type) as well as offer the opportunity to even show efficacy given how frequently FTO is overexpressed in cancer.
I don’t think it would be ethical to give healthy people Bisantrene at this stage even at low doses.
- Forums
- ASX - By Stock
- RAC
- Ann: Race investor briefing & updated presentation
Ann: Race investor briefing & updated presentation, page-35
-
-
- There are more pages in this discussion • 300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.66 |
Change
-0.040(2.35%) |
Mkt cap ! $283.7M |
Open | High | Low | Value | Volume |
$1.70 | $1.70 | $1.66 | $80.12K | 47.89K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 13907 | $1.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.67 | 1300 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1720 | 1.665 |
4 | 20642 | 1.660 |
1 | 1027 | 1.655 |
2 | 20534 | 1.650 |
2 | 7700 | 1.640 |
Price($) | Vol. | No. |
---|---|---|
1.675 | 402 | 3 |
1.680 | 1864 | 1 |
1.685 | 431 | 2 |
1.690 | 3000 | 1 |
1.700 | 4980 | 4 |
Last trade - 15.29pm 17/09/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |